NO20030713L - Oral faststoffdose vaksine - Google Patents

Oral faststoffdose vaksine

Info

Publication number
NO20030713L
NO20030713L NO20030713A NO20030713A NO20030713L NO 20030713 L NO20030713 L NO 20030713L NO 20030713 A NO20030713 A NO 20030713A NO 20030713 A NO20030713 A NO 20030713A NO 20030713 L NO20030713 L NO 20030713L
Authority
NO
Norway
Prior art keywords
oral solid
solid dose
dose vaccine
vaccine
oral
Prior art date
Application number
NO20030713A
Other languages
English (en)
Other versions
NO20030713D0 (no
Inventor
Vincent Vandevelde
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20030713D0 publication Critical patent/NO20030713D0/no
Publication of NO20030713L publication Critical patent/NO20030713L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20030713A 2000-08-15 2003-02-14 Oral faststoffdose vaksine NO20030713L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0020089.9A GB0020089D0 (en) 2000-08-15 2000-08-15 Vaccine Composition
PCT/IB2001/001711 WO2002013858A1 (en) 2000-08-15 2001-08-14 Oral solid dose vaccine

Publications (2)

Publication Number Publication Date
NO20030713D0 NO20030713D0 (no) 2003-02-14
NO20030713L true NO20030713L (no) 2003-04-11

Family

ID=9897656

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030713A NO20030713L (no) 2000-08-15 2003-02-14 Oral faststoffdose vaksine

Country Status (17)

Country Link
US (1) US20040013695A1 (no)
EP (1) EP1309344A1 (no)
JP (1) JP2004506020A (no)
KR (1) KR20030031978A (no)
CN (1) CN1842345A (no)
AU (2) AU2001286168B2 (no)
BR (1) BR0113301A (no)
CA (1) CA2424160A1 (no)
GB (1) GB0020089D0 (no)
HU (1) HUP0301697A3 (no)
IL (1) IL154404A0 (no)
MX (1) MXPA03001392A (no)
NO (1) NO20030713L (no)
NZ (1) NZ524164A (no)
PL (1) PL362481A1 (no)
WO (1) WO2002013858A1 (no)
ZA (1) ZA200301210B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
US20050084478A1 (en) * 2000-10-17 2005-04-21 Chih-Ping Liu Combination therapy using interferon-tau
US20050118138A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
US20050201981A1 (en) * 2004-03-10 2005-09-15 Chih-Ping Liu Method of optimizing treatment with interferon-tau
US7431920B2 (en) * 2000-07-19 2008-10-07 Pepgen Corporation Method of treating IL-10 deficiency
US20050226845A1 (en) * 2004-03-10 2005-10-13 Chih-Ping Liu Method of treatment using interferon-tau
US20040247565A1 (en) * 2000-07-19 2004-12-09 Chih-Ping Liu Method of treatment using interferon-tau
US20050118137A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US20020051794A1 (en) 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
IL162857A0 (en) * 2002-01-15 2005-11-20 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Oral vaccination
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
AU2004216559B2 (en) 2003-02-28 2010-05-27 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
JP5021309B2 (ja) * 2003-10-16 2012-09-05 ステファン ジョン ラルフ 免疫調節性組成物およびその使用方法
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
US20060078942A1 (en) * 2004-03-10 2006-04-13 Pepgen Corporation Method of treatment using interferon-tau
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
EP1854478A1 (en) * 2006-05-12 2007-11-14 Cytos Biotechnology AG Nicotine-carrier vaccine formulation
DK2187926T3 (da) 2007-09-11 2012-04-02 Univ Koebenhavn Forebyggelse af diabetes ved administration af gliadin
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
FR2960781B1 (fr) * 2010-06-07 2013-11-22 Sanofi Pasteur Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
US9956169B2 (en) * 2010-10-08 2018-05-01 R.P. Scherer Technologies, Llc Oral vaccine fast-dissolving dosage form using starch
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
CN103269716B (zh) 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂
WO2012103464A2 (en) * 2011-01-28 2012-08-02 Brian Pulliam Oral thin film vaccine preparation
IN2014MN01714A (no) * 2012-03-05 2015-05-29 Staat Der Nederlanden Vert Door De Minister Van Vwsministerie Van Volksgezondheid Welzijn En Sport D
US9433644B2 (en) 2013-07-25 2016-09-06 Rutgilli Pharmaceuticals, Llc Formulations and methods for treating oral inflammation, injury, or pain
EP3915579A1 (en) * 2013-12-31 2021-12-01 Infectious Disease Research Institute Single vial vaccine formulations
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN108289947A (zh) * 2015-11-27 2018-07-17 日东电工株式会社 流感疫苗干燥制剂和流感疫苗干燥制剂的制造方法
JP6916113B2 (ja) * 2015-11-27 2021-08-11 日東電工株式会社 口腔内投与用ワクチン医薬組成物及び口腔内投与用ワクチン医薬組成物の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
GB9722682D0 (en) * 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
AP1768A (en) * 1999-08-17 2007-08-16 Smithkline Beecham Biologicals S A Vaccine
KR100366608B1 (ko) * 2000-02-15 2003-01-09 마스터진(주) 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신

Also Published As

Publication number Publication date
NO20030713D0 (no) 2003-02-14
AU2001286168B2 (en) 2004-09-23
HUP0301697A3 (en) 2004-11-29
AU8616801A (en) 2002-02-25
JP2004506020A (ja) 2004-02-26
KR20030031978A (ko) 2003-04-23
WO2002013858A1 (en) 2002-02-21
US20040013695A1 (en) 2004-01-22
GB0020089D0 (en) 2000-10-04
HUP0301697A2 (hu) 2003-08-28
ZA200301210B (en) 2004-03-12
CA2424160A1 (en) 2002-02-21
EP1309344A1 (en) 2003-05-14
PL362481A1 (en) 2004-11-02
NZ524164A (en) 2004-10-29
BR0113301A (pt) 2003-07-15
CN1842345A (zh) 2006-10-04
IL154404A0 (en) 2003-09-17
MXPA03001392A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
NO20030713D0 (no) Oral faststoffdose vaksine
NO20031483L (no) Vaksine
NO20026175L (no) Vaksinesammensetning
EE04331B1 (et) Kiiresti lahustuv peroraalne ravimvorm
NO20024172L (no) Vaksine
NO20014325D0 (no) Vaksine
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
DK1335678T3 (da) Oralt behandlingssystem
ATE490327T1 (de) Impfstoffzusammensetzung
DK1199054T3 (da) Væskefrakturhånddel
CY2007031I1 (el) Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
DE60027029D1 (de) Kombinierte impfstoffzusammensetzungen
ATE355271T1 (de) Pharmazeutische zusammensetzung
DE60002650D1 (de) Öladjuvierter Impfstoff
DZ3219A1 (fr) Vaccin
DE60037282D1 (de) Zahnpflegemittel
DE60129238D1 (de) Pharmazeutische zusammensetzung
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
NO20040866L (no) Ny oral forlenget frigivelses doseringsform
IT1315517B1 (it) Impianto dentale
GB0008029D0 (en) New vaccine formulations
GB0014497D0 (en) Oral dosage form

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application